Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a "Spike-in" Clonal Sequence

Blood (2019) 134 (Supplement_1): 3380.

https://doi.org/10.1182/blood-2019-127672

Published: 2019

Journal Articles

Next-Generation Sequencing-Based Assay Shows High Clonal Characterization Success Rate for Plasma Cell Neoplasms, and Concordance with Flow Cytometry in Minimal Residual Disease Detection

Caleb Ho, MD, Mustafa Syed, MS, Mikhail Roshal, MD PhD, Kseniya Petrova-Drus, MD PhD, Christine Moung, MD, Jin Juan Yao, MD PhD, Wayne Yu, B.S, Lidia Maciag, Ryma Benayed, PhD, Malin Hultcrantz, MD PhD, Ahmet Dogan, MD PhD, Khedoudja Nafa, PhD, Ola Landgren, MD PhD, Maria E Arcila, MD

Blood (2018) 132 (Supplement 1): 4475.

https://doi.org/10.1182/blood-2018-99-115690

Published: 2018

Journal Articles

Next Generation Sequencing (NGS) Based IGH and TCR Clonality Assays Provide Excellent Specificity and Sensitivity for Routine Clonal Characterization and Monitoring of Lymphoproliferative Disorders

Maria E. Arcila, Mustafa Syed, MS, Wayne Yu, B.S, Hannah Kim, B.S, JinYuan Yao, MD, Caleb Ho, MD, Kseniya Petrova-Drus, Mikhail Roshal, MDPhD, Jae H. Park, MD, Ola Landgren, MD PhD, Ahmet Dogan, MD PhD, Khedoudja Nafa, PhD

Blood (2017) 130 (Supplement 1): 4017.

https://doi.org/10.1182/blood.V130.Suppl_1.4017.4017

Published: 2017

Journal Articles

Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia

Carmela Gurrieri, Khedoudja Nafa, Taha Merghoub, Rosa Bernardi, Paola Capodieci, Andrea Biondi, Stephen Nimer, Dan Douer, Carlos Cordon-Cardo, Robert Gallagher, Pier Paolo Pandolfi

Blood (2004) 103 (6): 2358–2362.

https://doi.org/10.1182/blood-2003-07-2200

Published: 2004

Journal Articles

Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria

Anastasios Karadimitris, John S. Manavalan, Howard T. Thaler, Rosario Notaro, David J. Araten, Khedoudja Nafa, Irene A.G. Roberts, Marc E. Weksler, Lucio Luzzatto

Blood (2000) 96 (7): 2613–2620.

https://doi.org/10.1182/blood.V96.7.2613

Published: 2000

NARROW

Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a "Spike-in" Clonal Sequence

Next-Generation Sequencing-Based Assay Shows High Clonal Characterization Success Rate for Plasma Cell Neoplasms, and Concordance with Flow Cytometry in Minimal Residual Disease Detection

Next Generation Sequencing (NGS) Based IGH and TCR Clonality Assays Provide Excellent Specificity and Sensitivity for Routine Clonal Characterization and Monitoring of Lymphoproliferative Disorders

Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia

Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria

Email alerts

ASH Publications

American Society of Hematology

Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a "Spike-in" Clonal Sequence

Next-Generation Sequencing-Based Assay Shows High Clonal Characterization Success Rate for Plasma Cell Neoplasms, and Concordance with Flow Cytometry in Minimal Residual Disease Detection

Next Generation Sequencing (NGS) Based IGH and TCR Clonality Assays Provide Excellent Specificity and Sensitivity for Routine Clonal Characterization and Monitoring of Lymphoproliferative Disorders

Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia

Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only